NCT02893826 - Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

March 31, 2018

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Interventions

DRUG

EG-1962 (nimodipine microparticles)

DRUG

Enteral Nimodipine

Trial Locations (4)

University of Maryland Medical Systems, Baltimore

Dignity Health; St. Joseph's Hospital and Medical Center, Phoenix

University of California San Francisco, San Francisco

University of Alberta Hospital/Mackenzie Health Sciences Centre, Edmonton